Elanco Animal Health (ELAN) Liabilities and Shareholders Equity (2017 - 2026)

Elanco Animal Health (ELAN) has 10 years of Liabilities and Shareholders Equity data on file, last reported at $13.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 2.17% year-over-year to $13.2 billion; the trailing twelve-month figure through Mar 2026 stood at $53.9 billion (up 2.42% YoY), and the FY2025 full-year result was $13.4 billion, up 5.9% from the prior year.
• Liabilities and Shareholders Equity retreated to $13.2 billion in Q1 2026, from $13.4 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $16.3 billion in Q1 2022 to a low of $12.6 billion in Q4 2024.
• A 5-year average of $14.3 billion and a median of $14.0 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity declined 12.86% in 2024 and advanced 5.9% in 2025, its largest moves.
• Tracing ELAN's Liabilities and Shareholders Equity over 5 years: stood at $15.5 billion in 2022, then retreated by 7.29% to $14.4 billion in 2023, then dropped by 12.17% to $12.6 billion in 2024, then rose by 5.9% to $13.4 billion in 2025, then slipped by 1.02% to $13.2 billion in 2026.
• Business Quant data shows ELAN's Liabilities and Shareholders Equity at $13.2 billion in Q1 2026, $13.4 billion in Q4 2025, and $13.6 billion in Q3 2025.